Citations

Showing 10 of 108083 citations.

National Certification in Critical Care Echocardiography: Its Time Has Come
Díaz‐Gómez, José L. , Frankel, Heidi L., Hernandez, Antonio , Díaz-Gómez, José L

Mayo Clinic

Critical Care Medicine | October 15, 2017 | Volume: 45 | Issue: 11 | Pages: 1801-1804

10.1097/ccm.0000000000002707 | PMID 29028695 Get It

Muscle‐specific differences in expression and phosphorylation of the Janus kinase 2/Signal Transducer and Activator of Transcription 3 following long‐term mechanical ventilation and immobilization in rats
Salah, Heba , Fury, Wen , Gromada, Jesper , Bai, Yu , Tchkonia, Tamar , Kirkland, James L. , Tchkonia, T , Bai, Y., Larsson, Lars

Mayo Clinic

Acta Physiologica | October 15, 2017 | Volume: 222 | Issue: 3 | Pages: No page available

10.1111/apha.12980 | PMID 29032602 Get It

AbstractAimMuscle wasting is one of the factors most strongly predicting mortality and morbidity in critically ill intensive care unit (ICU). This muscle wasting affects both limb and respiratory muscles, but the understanding of underlying mechanisms and muscle‐specific differences remains incomplete. This study aimed at investigating the temporal expression and phosphorylation of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway in muscle wasting associated with the ICU condition to characterize the JAK/STAT proteins and the related changes leading or responding to their activation during exposure to the ICU condition.MethodsA novel experimental ICU model allowing long‐term exposure to the ICU condition, immobilization and mechanical ventilation, was used in this study. Rats were pharmacologically paralysed by post‐synaptic neuromuscular blockade and mechanically ventilated for durations varying between 6 hours and 14 days to study muscle‐specific differences in the temporal activation of the JAK/STAT pathway in plantaris, intercostal and diaphragm muscles.ResultsThe JAK2/STAT3 pathway was significantly activated irrespective of muscle, but muscle‐specific differences were observed in the temporal activation pattern between plantaris, intercostal and diaphragm muscles.ConclusionThe JAK2/STAT3 pathway was differentially activated in plantaris, intercostal and diaphragm muscles in response to the ICU condition. Thus, JAK2/STAT3 inhibitors may provide an attractive pharmacological intervention strategy in immobilized ICU patients, but further experimental studies are required in the study of muscle‐specific effects on muscle mass and function in response to both short‐ and long‐term exposure to the ICU condition prior to the translation into clinical research and practice.
Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos)
Yokoe, Masamichi, Hata, Jiro , Takada, Tadahiro , Strasberg, Steven M. , Asbun, Horacio J. , Wakabayashi, Go , Kozaka, Kazuto , Endo, Itaru , Deziel, Daniel J., Miura, Fumihiko, Okamoto, Kohji , Hwang, Tsann‐Long , Huang, Wayne Shih‐Wei, Ker, Chen‐Guo , Chen, Miin‐Fu , Choi, In‐Seok , Noguchi, Yoshinori , Shikata, Satoru , Higuchi, Ryota , Gabata, Toshifumi , Mori, Yasuhisa , Iwashita, Yukio , Hibi, Taizo , Jagannath, P., Jonas, Eduard , Liau, Kui‐Hin, Dervenis, Christos, Gouma, Dirk J., Cherqui, Daniel , Belli, Giulio, Garden, O. James , Giménez, Mariano , Santibáñes, Eduardo de , Umezawa, Akiko , Supe, Avinash , Pitt, Henry A. , Singh, Harjit , Chan, Angus C. W., Lau, Wan Yee , Sugioka, Atsushi , Asai, Koji , Gomi, Harumi , Itoi, Takao , Kiriyama, Seiki , Yoshida, Masahiro , Mayumi, Toshihiko , Matsumura, Naoki , Tokumura, Hiromi, Kitano, Seigo, Inui, Kazuo, Sumiyama, Yoshinobu, Yamamoto, Masakazu , Han, Ho-Seong , Yoon, Yoo-Seok , Yoon, Dong Sup , Ukai, Tomohiko , Suzuki, Kenji S. , Teoh, Anthony Yuen Bun , Honda, Goro , Hirata, Koichi , Jonas, Eduard

Mayo Clinic

Journal of Hepato-Biliary-Pancreatic Sciences | October 15, 2017 | Volume: 25 | Issue: 1 | Pages: 41-54

10.1002/jhbp.515 | PMID 29032636 Get It

Abstract The Tokyo Guidelines 2013 (TG13) for acute cholangitis and cholecystitis were globally disseminated and various clinical studies about the management of acute cholecystitis were reported by many researchers and clinicians from all over the world. The 1 st edition of the Tokyo Guidelines 2007 ( TG 07) was revised in 2013. According to that revision, the TG 13 diagnostic criteria of acute cholecystitis provided better specificity and higher diagnostic accuracy. Thorough our literature search about diagnostic criteria for acute cholecystitis, new and strong evidence that had been released from 2013 to 2017 was not found with serious and important issues about using TG 13 diagnostic criteria of acute cholecystitis. On the other hand, the TG 13 severity grading for acute cholecystitis has been validated in numerous studies. As a result of these reviews, the TG 13 severity grading for acute cholecystitis was significantly associated with parameters including 30‐day overall mortality, length of hospital stay, conversion rates to open surgery, and medical costs. In terms of severity assessment, breakthrough and intensive literature for revising severity grading was not reported. Consequently, TG 13 diagnostic criteria and severity grading were judged from numerous validation studies as useful indicators in clinical practice and adopted as TG 18/ TG 13 diagnostic criteria and severity grading of acute cholecystitis without any modification. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47 . Related clinical questions and references are also included.
Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial
Chuong, Michael D. , Hartsell, William F. , Larson, Gary, Laramore, George E. , Rossi, Carl J., Wilkinson, J. Ben, Kaiser, Adeel , Vargas, Carlos , Tsai, Henry K.

Mayo Clinic

Acta Oncologica | October 14, 2017 | Volume: 57 | Issue: 3 | Pages: 368-374

10.1080/0284186x.2017.1388539 | PMID 29034790 Get It

Neurokinin B Regulates Gonadotropin Secretion, Ovarian Follicle Growth, and the Timing of Ovulation in Healthy Women
Skorupskaite, Karolina , Veldhuis, Johannes D. , George, Jyothis T. , Anderson, Richard A.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | October 14, 2017 | Volume: 103 | Issue: 1 | Pages: 95-104

10.1210/jc.2017-01306 | PMID 29040622 Get It

Abstract Context Neurokinin B (NKB) is obligate for human puberty, but its role in adult female gonadotropin secretion and ovarian follicle growth is unknown. Objective To investigate antagonism of NKB on pulsatile gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH) secretion and ovarian follicle development in healthy women. Design Open investigation of the effects of a neurokinin-3 receptor (NK3R) antagonist (NK3Ra) vs a no-treatment control cycle. Setting Clinical research facility. Patients or other participants Healthy women with regular menses (n = 13). Intervention(s) NK3Ra MLE4901 40 mg taken orally twice daily from cycle day 5 to 6 for 7 days. Main outcome measure(s) LH secretion, ovarian follicle growth, and timing of ovulation. Results NK3Ra administration reduced basal LH secretion without a change in pulse frequency and delayed the LH surge by 7 days, the duration of treatment [mean cycle day ± standard error of the mean (SEM), 22 ± 1 days vs 15 ± 1 days in control cycles; P = 0.0006]. Follicle growth (mean diameter at the end of administration of NK3Ra administration ± SEM, 9.3 ± 0.4 mm vs 15.1 ± 0.9 mm in control cycles; P < 0.0001) and rising estradiol concentrations (mean ± SEM, 166 ± 29 pmol/L vs 446 ± 86 pmol/L in control cycles; P < 0.0001) were prevented. After treatment, follicle development resumed and normal preovulatory follicle diameter and estradiol concentrations were demonstrated. Postovulatory progesterone rise was similarly delayed (peak cycle day, 30 ± 2 vs 22 ± 1; P = 0.002) and cycle length was prolonged (35 ± 1 days vs 29 ± 1 days in control cycles; P = 0.0003) but luteal progesterone excretion was unaffected by the NK3Ra (LH surge day +7 mean urinary progesterone levels ± SEM, 58 ± 10 pmol/mol vs 48±7 pmol/mol creatinine in control cycles; nonsignificant). Conclusion These data demonstrate the involvement of NKB-NK3R signaling in the physiological regulation of GnRH/LH secretion, determining normal follicle development in women.
Variables That Impact Medical Malpractice Claims Involving Plastic Surgeons in the United States
Boyll, Piper, Kang, Paul , Mahabir, Raman C. , Bernard, Robert W. , Mahabir, Raman

Mayo Clinic

Aesthetic Surgery Journal | October 14, 2017 | Volume: 38 | Issue: 7 | Pages: 785-792

10.1093/asj/sjx182 | PMID 29040404 Get It

Society for the Advancement of Transplant Anesthesia: Liver Transplant Anesthesia Fellowship—White Paper Advocating Measurable Proficiency in Transplant Specialties Training
Crouch, Cara , Zerillo, Jeron , Pretto, Ernesto A. , Planinsic, Raymond M. , Kim, Sang , Nicolau‐Raducu, Ramona , Adelmann, Dieter , Elia, Elia, Wray, Christopher , Srinivas, Coimbatore, Mandell, M. Susan , Chadha, Ryan

Mayo Clinic

Seminars in Cardiothoracic and Vascular Anesthesia | October 14, 2017 | Volume: 21 | Issue: 4 | Pages: 352-356

10.1177/1089253217737043 | PMID 29029588 Get It

The anesthesia community has openly debated if the care of transplant patients was generalist or specialist care ever since the publication of an opinion paper in 1999 recommended subspecialty training in the field of liver transplantation anesthesia. In the past decade, liver transplant anesthesia has become more complex with a sicker patient population and evolving evidence-based practices. Transplant training is currently not required for accreditation or certification in anesthesiology, and not all anesthesia residency programs are associated with transplant centers. Yet there is evidence that patient outcome is affected by the experience of the anesthesiologist with liver transplants as part of a multidisciplinary care team. Requests for a formal review of the inequities in training opportunities and requirements led the Society for the Advancement for Transplant Anesthesia (SATA) to begin the task of developing post-graduate fellowship training recommendations. In this article, members of the SATA Working Group on Transplant Anesthesia Education present their reasoning for specialized education and conclusions about which pathways can better prepare trainees to care for complex transplant patients.
Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia
Dassau, Eyal , Pinsker, Jordan E. , Kudva, Yogish C. , Brown, Sue A. , Gondhalekar, Ravi , Man, Chiara Dalla , Patek, Steve, Schiavon, Michele , Dadlani, Vikash, Dasanayake, Isuru , Church, Mei Mei , Carter, Rickey E. , Bevier, Wendy C. , Huyett, Lauren M. , Hughes, Jonathan , Anderson, Stacey M. , Lv, Dayu, Schertz, Elaine, Emory, Emma, McCrady-Spitzer, Shelly , Jean, Tyler, Bradley, Paige K., Hinshaw, Ling , Sanz, Alejandro José Laguna , Basu, Ananda , Kovatchev, Boris , McCrady-Spitzer, Shelly K, Cobelli, Claudio , Doyle, Francis J , Dalla Man, Chiara , Carter, Rickey E , Kovatchev, Boris , Cobelli, Claudio , Doyle, Francis J. , Schiavon, Michele

Mayo Clinic

Diabetes Care | October 14, 2017 | Volume: 40 | Issue: 12 | Pages: 1719-1726

10.2337/dc17-1188 | PMID 29030383 Get It

OBJECTIVE Artificial pancreas (AP) systems are best positioned for optimal treatment of type 1 diabetes (T1D) and are currently being tested in outpatient clinical trials. Our consortium developed and tested a novel adaptive AP in an outpatient, single-arm, uncontrolled multicenter clinical trial lasting 12 weeks. RESEARCH DESIGN AND METHODS Thirty adults with T1D completed a continuous glucose monitor (CGM)-augmented 1-week sensor-augmented pump (SAP) period. After the AP was started, basal insulin delivery settings used by the AP for initialization were adapted weekly, and carbohydrate ratios were adapted every 4 weeks by an algorithm running on a cloud-based server, with automatic data upload from devices. Adaptations were reviewed by expert study clinicians and patients. The primary end point was change in hemoglobin A1c (HbA1c). Outcomes are reported adhering to consensus recommendations on reporting of AP trials. RESULTS Twenty-nine patients completed the trial. HbA1c, 7.0 ± 0.8% at the start of AP use, improved to 6.7 ± 0.6% after 12 weeks (−0.3, 95% CI −0.5 to −0.2, P < 0.001). Compared with the SAP run-in, CGM time spent in the hypoglycemic range improved during the day from 5.0 to 1.9% (−3.1, 95% CI −4.1 to −2.1, P < 0.001) and overnight from 4.1 to 1.1% (−3.1, 95% CI −4.2 to −1.9, P < 0.001). Whereas carbohydrate ratios were adapted to a larger extent initially with minimal changes thereafter, basal insulin was adapted throughout. Approximately 10% of adaptation recommendations were manually overridden. There were no protocol-related serious adverse events. CONCLUSIONS Use of our novel adaptive AP yielded significant reductions in HbA1c and hypoglycemia.
Patient and Spousal Health and Outcomes in Heart Failure
Roger, Véronique L. , Weston, Susan A., Bangerter, Lauren R. , Killian, Jill M. , Dunlay, Shannon M. , Griffin, Joan M.

Mayo Clinic

Circulation: Heart Failure | October 14, 2017 | Volume: 10 | Issue: 10 | Pages: No page available

10.1161/circheartfailure.117.004088 | PMID 29030371 Get It

Background: A diagnosis of heart failure (HF) often requires a comprehensive lifestyle change to maintain disease stability. When patients with HF are married, the spouse frequently assumes the caregiving role. Our objectives were to describe the health of spouses of married patients with HF, and examine whether the health of a spouse impacts patient outcomes. Methods and Results: We identified 905 patients that were married at the time of incident HF diagnosis in Olmsted County, MN, from 2000 to 2012. Using Rochester Epidemiology Project resources, the patient and their spouse’s comprehensive longitudinal health histories were linked. Spousal health at patient HF diagnosis was assessed by comorbidity burden, self-reported difficulty with activities of daily living and prior hospitalizations. The associations of spousal health with patient outcomes and patient death with spousal outcomes were examined using Cox and Andersen–Gill models. Spouses of patients with HF were elderly (mean age, 71 years), often had comorbid conditions, and 16% had difficulty with ≥1 activities of daily living. After adjustment for patient age, sex, and comorbidity, there were no independent associations of spousal health and patient risk of death or hospitalization after HF diagnosis. However, the risk of hospitalization (adjusted hazard ratio, 1.34; 95% confidence interval, 1.11–1.60; P =0.002) and death (hazard ratio, 2.10; 95% confidence interval, 1.60–2.75; P <0.001) increased in the surviving spouse after patient death. Conclusions: We found no evidence that the health of a spouse impacts patient outcomes after HF diagnosis. However, after a patient with HF dies, their surviving spouse’s risk of hospitalization and death increases.